- Home
- ARMK vs BRKR Comparison
ARMK vs BRKR Comparison
Compare ARMK & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMK
- BRKR
- Stock Information
- Founded
- ARMK 1959
- BRKR 1960
- Country
- ARMK United States
- BRKR United States
- Employees
- ARMK N/A
- BRKR N/A
- Industry
- ARMK Restaurants
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- ARMK Consumer Discretionary
- BRKR Industrials
- Exchange
- ARMK Nasdaq
- BRKR Nasdaq
- Market Cap
- ARMK 10.1B
- BRKR 5.3B
- IPO Year
- ARMK 2013
- BRKR 2000
- Fundamental
- Price
- ARMK $37.59
- BRKR $39.00
- Analyst Decision
- ARMK Strong Buy
- BRKR Buy
- Analyst Count
- ARMK 9
- BRKR 10
- Target Price
- ARMK $45.67
- BRKR $46.67
- AVG Volume (30 Days)
- ARMK 2.3M
- BRKR 3.3M
- Earning Date
- ARMK 11-17-2025
- BRKR 11-03-2025
- Dividend Yield
- ARMK 1.11%
- BRKR 0.50%
- EPS Growth
- ARMK 3.13
- BRKR N/A
- EPS
- ARMK 1.36
- BRKR N/A
- Revenue
- ARMK $17,874,782,000.00
- BRKR $3,438,900,000.00
- Revenue This Year
- ARMK $9.17
- BRKR $4.27
- Revenue Next Year
- ARMK $5.82
- BRKR $1.34
- P/E Ratio
- ARMK $27.75
- BRKR N/A
- Revenue Growth
- ARMK 4.02
- BRKR 6.10
- 52 Week Low
- ARMK $29.92
- BRKR $28.53
- 52 Week High
- ARMK $44.49
- BRKR $64.64
- Technical
- Relative Strength Index (RSI)
- ARMK 36.93
- BRKR 56.55
- Support Level
- ARMK $37.29
- BRKR $36.11
- Resistance Level
- ARMK $40.26
- BRKR $40.74
- Average True Range (ATR)
- ARMK 0.71
- BRKR 1.74
- MACD
- ARMK -0.24
- BRKR -0.02
- Stochastic Oscillator
- ARMK 9.95
- BRKR 58.15
About ARMK Aramark
Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, operates as a food service company providing facility management and workplace solutions. The company primarily generates revenue from its North American food and support services segment, serving various clients including schools, healthcare facilities, and entertainment venues.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.